X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases
- PMID: 24568342
- PMCID: PMC3983375
- DOI: 10.1021/jm401712t
X-ray structural and biological evaluation of a series of potent and highly selective inhibitors of human coronavirus papain-like proteases
Abstract
Structure-guided design was used to generate a series of noncovalent inhibitors with nanomolar potency against the papain-like protease (PLpro) from the SARS coronavirus (CoV). A number of inhibitors exhibit antiviral activity against SARS-CoV infected Vero E6 cells and broadened specificity toward the homologous PLP2 enzyme from the human coronavirus NL63. Selectivity and cytotoxicity studies established a more than 100-fold preference for the coronaviral enzyme over homologous human deubiquitinating enzymes (DUBs), and no significant cytotoxicity in Vero E6 and HEK293 cell lines is observed. X-ray structural analyses of inhibitor-bound crystal structures revealed subtle differences between binding modes of the initial benzodioxolane lead (15g) and the most potent analogues 3k and 3j, featuring a monofluoro substitution at para and meta positions of the benzyl ring, respectively. Finally, the less lipophilic bis(amide) 3e and methoxypyridine 5c exhibit significantly improved metabolic stability and are viable candidates for advancing to in vivo studies.
Figures
Similar articles
-
Structure-based design, synthesis, and biological evaluation of a series of novel and reversible inhibitors for the severe acute respiratory syndrome-coronavirus papain-like protease.J Med Chem. 2009 Aug 27;52(16):5228-40. doi: 10.1021/jm900611t. J Med Chem. 2009. PMID: 19645480 Free PMC article.
-
The SARS-coronavirus papain-like protease: structure, function and inhibition by designed antiviral compounds.Antiviral Res. 2015 Mar;115:21-38. doi: 10.1016/j.antiviral.2014.12.015. Epub 2014 Dec 29. Antiviral Res. 2015. PMID: 25554382 Free PMC article. Review.
-
Severe acute respiratory syndrome coronavirus papain-like novel protease inhibitors: design, synthesis, protein-ligand X-ray structure and biological evaluation.J Med Chem. 2010 Jul 8;53(13):4968-79. doi: 10.1021/jm1004489. J Med Chem. 2010. PMID: 20527968 Free PMC article.
-
A chimeric virus-mouse model system for evaluating the function and inhibition of papain-like proteases of emerging coronaviruses.J Virol. 2014 Oct;88(20):11825-33. doi: 10.1128/JVI.01749-14. Epub 2014 Aug 6. J Virol. 2014. PMID: 25100850 Free PMC article.
-
Insights into Coronavirus Papain-like Protease Structure, Function and Inhibitors.Protein Pept Lett. 2022;29(7):574-583. doi: 10.2174/0929866529666220602094016. Protein Pept Lett. 2022. PMID: 35657040 Review.
Cited by
-
Identification of Triazolopyrimidinyl Scaffold SARS-CoV-2 Papain-Like Protease (PLpro) Inhibitor.Pharmaceutics. 2024 Jan 25;16(2):169. doi: 10.3390/pharmaceutics16020169. Pharmaceutics. 2024. PMID: 38399230 Free PMC article.
-
Integrating Transcriptome and Chemical Analyses to Provide Insights into Biosynthesis of Terpenoids and Flavonoids in the Medicinal Industrial Crop Andrographis paniculate and Its Antiviral Medicinal Parts.Molecules. 2024 Feb 14;29(4):852. doi: 10.3390/molecules29040852. Molecules. 2024. PMID: 38398604 Free PMC article.
-
Targeting SARS-CoV-2 nonstructural protein 3: Function, structure, inhibition, and perspective in drug discovery.Drug Discov Today. 2024 Jan;29(1):103832. doi: 10.1016/j.drudis.2023.103832. Epub 2023 Nov 15. Drug Discov Today. 2024. PMID: 37977285 Review.
-
Computational study of the binding orientation and affinity of noncovalent inhibitors of the papain-like protease (PLpro) from SARS-CoV-1 considering the protein flexibility by using molecular dynamics and cross-docking.Front Mol Biosci. 2023 Jun 23;10:1215499. doi: 10.3389/fmolb.2023.1215499. eCollection 2023. Front Mol Biosci. 2023. PMID: 37426421 Free PMC article.
-
Discovery of Chalcone-Based Hybrid Structures as High Affinity and Site-Specific Inhibitors against SARS-CoV-2: A Comprehensive Structural Analysis Based on Various Host-Based and Viral Targets.Int J Mol Sci. 2023 May 15;24(10):8789. doi: 10.3390/ijms24108789. Int J Mol Sci. 2023. PMID: 37240149 Free PMC article.
References
-
- Summary Table of SARS Cases by Country, 1 November 2002–7 August 2003. WHO: Geneva, August 15, 2003; http://www.who.int/csr/sars/country/2003_08_15/en/.
-
- van Boheemen S.; Zaki A. M.; Bestebroer T. M.; de Graaf M.; Victor S.; Osterhaus A. D.; Haagmans B. L.; Fouchier R. A.. Genomic Analysis for a Newly Isolated Human Betacoronavirus Lineage 2C. Submitted Sep 26, 2012.
- Bermingham A.; Chand M.; Brown C.; Aarons E.; Tong C.; Langrish C.; Hoschler K.; Brown K.; Galiano M.; Myers R.; Pebody R.; Green H.; Boddington N.; Gopal R.; Price N.; Newsholme W.; Drosten C.; Fouchier R.; Zambon M. Severe respiratory illness caused by a novel coronavirus, in a patient transferred to the United Kingdom from the Middle East, September 2012. Eurosurveillance 2012, 1740pii=20290. - PubMed
- Pebody R. G.; Chand M. A.; Thomas H. L.; Green H. K.; Boddington N. L.; Carvalho C.; Brown C. S.; Anderson S. R.; Rooney C.; Crawley-Boevey E.; Irwin D. J.; Aarons E.; Tong C.; Newsholme W.; Price N.; Langrish C.; Tucker D.; Zhao H.; Phin N.; Crofts J.; Bermingham A.; Gilgunn-Jones E.; Brown K. E.; Evans B.; Catchpole M.; Watson J. M. The United Kingdom public health response to an imported laboratory confirmed case of a novel coronavirus in September 2012. Eurosurveillance 2012, 174020292. - PubMed
-
- de Groot R. J.; Baker S. C.; Baric R. S.; Brown C. S.; Drosten C.; Enjuanes L.; Fouchier R. A.; Galiano M.; Gorbalenya A. E.; Memish Z.; Perlman S.; Poon L. L.; Snijder E. J.; Stephens G. M.; Woo P. C.; Zaki A. M.; Zambon M.; Ziebuhr J. Middle East Respiratory Syndrome Coronavirus (MERS-CoV): Announcement of the Coronavirus Study Group. J. Virol. 2013, 87, 7790–7792. - PMC - PubMed
-
- Kindler E.; Jonsdottir H. R.; Muth D.; Hamming O. J.; Hartmann R.; Rodriguez R.; Geffers R.; Fouchier R. A.; Drosten C.; Muller M. A.; Dijkman R.; Thiel V. Efficient Replication of the Novel Human Betacoronavirus EMC on Primary Human Epithelium Highlights Its Zoonotic Potential. mBio 2013, 41e00611-12. - PMC - PubMed
-
- van Boheemen S.; de Graaf M.; Lauber C.; Bestebroer T. M.; Raj V. S.; Zaki A. M.; Osterhaus A. D.; Haagmans B. L.; Gorbalenya A. E.; Snijder E. J.; Fouchier R. A. Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans. mBio 2012, 36e00473-12. - PMC - PubMed
Publication types
MeSH terms
Substances
Associated data
- Actions
- Actions
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Chemical Information
Molecular Biology Databases
Miscellaneous
